{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:13:30Z","timestamp":1793121210973,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajog.2022.03.051","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:32:41Z","timestamp":1648553561000},"page":"401-413.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis"],"prefix":"10.1016","volume":"227","author":[{"given":"Ana Raquel","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Montoya-Botero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos P.","family":"Polyzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.03.051_bib1","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40265-020-01324-w","article-title":"Current therapeutic options for controlled ovarian stimulation in assisted reproductive technology","volume":"80","author":"Racca","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.ajog.2022.03.051_bib2","first-page":"2010","article-title":"Cumulative live birth rates and number of oocytes retrieved in women of advanced age. A single centre analysis including 4500 women \u226538 years old","volume":"33","author":"Devesa","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in\u00a0vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ajog.2022.03.051_bib4","first-page":"2703","article-title":"Cumulative live birth rate: time for a consensus?","volume":"30","author":"Maheshwari","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.rbmo.2013.11.010","article-title":"Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF\/ICSI","volume":"28","author":"Polyzos","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2022.03.051_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10815-015-0476-4","article-title":"Live birth rates in the different combinations of the Bologna criteria poor ovarian responders: a validation study","volume":"32","author":"La Marca","year":"2015","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2022.03.051_bib7","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/deaa183","article-title":"SAY NO to mild ovarian stimulation for all poor responders: it is time to realize that not all poor responders are the same","volume":"35","author":"Polyzos","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/humupd\/dmz046","article-title":"Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis","volume":"26","author":"Zhang","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2022.03.051_bib9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/humrep\/dew028","article-title":"Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial","volume":"31","author":"Bosdou","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.fertnstert.2014.03.044","article-title":"A\u00a0randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in\u00a0vitro fertilization outcomes in poor responders","volume":"102","author":"Yeung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.12717\/DR.2014.18.3.145","article-title":"Ovarian features after 2 weeks, 3 weeks and 4 weeks transdermal testosterone gel treatment and their associated effect on IVF outcomes in poor responders","volume":"18","author":"Kim","year":"2014","journal-title":"Dev Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejogrb.2017.09.006","article-title":"Efficacy of dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): a proof of principle double blinded randomized placebo controlled trial","volume":"218","author":"Narkwichean","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10","key":"10.1016\/j.ajog.2022.03.051_bib13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ajog.2022.03.051_bib14","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The international glossary on infertility and fertility care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib15","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime, 2021. Available from gradepro.org."},{"key":"10.1016\/j.ajog.2022.03.051_bib16","unstructured":"RStudio Team (2020). RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. http:\/\/www.rstudio.com\/"},{"key":"10.1016\/j.ajog.2022.03.051_bib18","doi-asserted-by":"crossref","unstructured":"Viechtbauer W (2010). \u201cConducting meta-analyses in R with the metafor package.\u201d J Stat Softw, 36(3), 1-48.","DOI":"10.18637\/jss.v036.i03"},{"issue":"4","key":"10.1016\/j.ajog.2022.03.051_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/j.ajog.2022.03.051_bib20","unstructured":"Ggplot WH. Elegant graphics for data analysis. (Springer-Verla, ed.). 2016. Available at: https:\/\/ggplot2.tidyverse.org. Accessed October 30, 2021."},{"key":"10.1016\/j.ajog.2022.03.051_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajog.2022.03.051_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2022.03.051_bib24","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ajog.2022.03.051_bib25","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1037\/a0033242","article-title":"P-curve: a key to the file-drawer","volume":"143","author":"Simonsohn","year":"2014","journal-title":"J\u00a0Exp Psychol Gen"},{"key":"10.1016\/j.ajog.2022.03.051_bib26","series-title":"Publication bias in meta-analysis: prevention, assessment and adjustments","first-page":"11","article-title":"Publication bias: recognizing the problem, understanding its origins and scope, and preventing harm","author":"Dickersin","year":"2005"},{"issue":"Suppl 4","key":"10.1016\/j.ajog.2022.03.051_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajog.2022.03.051_bib29","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1530\/REP-14-0517","article-title":"Role of androgens in normal and pathological ovarian function","volume":"149","author":"Walters","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2022.03.051_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.fertnstert.2003.11.062","article-title":"Androgen replacement therapy in women","volume":"82","author":"Cameron","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ajog.2022.03.051_bib31","first-page":"340","article-title":"Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle","volume":"39","author":"Abramson","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ajog.2022.03.051_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016260","article-title":"Androgen metabolism and the menopause","volume":"16","author":"Longcope","year":"1998","journal-title":"Semin Reprod Med"},{"issue":"Suppl 4","key":"10.1016\/j.ajog.2022.03.051_bib33","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0015-0282(02)02986-2","article-title":"Estrogen replacement therapy: effects on the endogenous androgen milieu","volume":"77","author":"Simon","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib34","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2022.03.051_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.026","article-title":"Role of androgens in the ovary","volume":"465","author":"Walters","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajog.2022.03.051_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fendo.2019.00388","article-title":"Polycystic ovary syndrome and NC-CAH: distinct characteristics and common findings. A systematic review","volume":"10","author":"Papadakis","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2022.03.051_bib38","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI2081","article-title":"Androgens stimulate early stages of follicular growth in the primate ovary","volume":"101","author":"Vendola","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2022.03.051_bib39","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/humrep\/14.9.2328","article-title":"Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary","volume":"14","author":"Vendola","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib40","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2009-0751","article-title":"Testosterone induces redistribution of forkhead box-3a and down-regulation of growth and differentiation factor 9 messenger ribonucleic acid expression at early stage of mouse folliculogenesis","volume":"151","author":"Yang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2022.03.051_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humrep\/det408","article-title":"Effects of dehydroepiandrosterone on in\u00a0vivo ovine follicular development","volume":"29","author":"Narkwichean","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/en.2016-1538","article-title":"Androgen stimulates growth of mouse preantral follicles in\u00a0vitro: interaction with follicle-stimulating hormone and with growth factors of the TGF\u03b2 super family","volume":"158","author":"Laird","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2022.03.051_bib43","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1073\/pnas.1318978111","article-title":"Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression","volume":"111","author":"Sen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2022.03.051_bib44","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1210\/jcem.84.8.5929","article-title":"Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development","volume":"84","author":"Weil","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib45","first-page":"31","article-title":"Androgen potentiates the expression of FSH receptor and supports preantral follicle development in mice","volume":"12","author":"Fujibe","year":"2019","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2022.03.051_bib46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/rep.0.1230527","article-title":"Increased ovulation rate in gilts treated with dihydrotestosterone","volume":"123","author":"C\u00e1rdenas","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2022.03.051_bib47","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1073\/pnas.0404372101","article-title":"Subfertility and defective folliculogenesis in female mice lacking androgen receptor","volume":"101","author":"Hu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajog.2022.03.051_bib48","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1210\/en.2007-0248","article-title":"Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility","volume":"148","author":"Walters","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2022.03.051_bib49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000487762","article-title":"The role of central androgen receptor actions in regulating the hypothalamic-pituitary-ovarian axis","volume":"106","author":"Walters","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ajog.2022.03.051_bib50","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1210\/me.2010-0006","article-title":"Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function","volume":"24","author":"Sen","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajog.2022.03.051_bib51","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1210\/en.2008-1750","article-title":"Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function","volume":"150","author":"Walters","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2022.03.051_bib52","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/me.2014-1154","article-title":"wu2014.conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice","volume":"28","author":"Wu","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajog.2022.03.051_bib53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2006-1697","article-title":"Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-M\u00fcllerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries","volume":"92","author":"Rice","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/oxfordjournals.humrep.a137614","article-title":"Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression","volume":"7","author":"Horie","year":"1992","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib55","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/oxfordjournals.humrep.a138757","article-title":"Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes","volume":"9","author":"Suzuki","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/molehr\/gaq073","article-title":"In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA","volume":"17","author":"Nielsen","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib57","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/humrep\/15.10.2129","article-title":"Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series","volume":"15","author":"Casson","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib58","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/jc.2015-1194","article-title":"Antral follicle priming before intracytoplasmic sperm injection in previously diagnosed low responders: a randomized controlled trial (FOLLPRIM)","volume":"100","author":"Escriva","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib59","doi-asserted-by":"crossref","first-page":"653857","DOI":"10.3389\/fendo.2021.653857","article-title":"The role of androgen supplementation in women With diminished ovarian reserve: time to randomize, not meta-analyze","volume":"12","author":"Neves","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2022.03.051_bib60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jc.2012-3071","article-title":"A\u00a0randomized double-blinded placebo-controlled trial on the effect of dehydroepiandrosterone for 16 weeks on ovarian response markers in women with primary ovarian insufficiency","volume":"98","author":"Yeung","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib61","first-page":"3","article-title":"The effect of testosterone gel on fertility outcomes in women with a poor response in in\u00a0vitro fertilization cycles: a pilot randomized clinical trial","volume":"23","author":"Saharkhiz","year":"2018","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.ajog.2022.03.051_bib62","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/humrep\/dei481","article-title":"Effects\u00a0of transdermal testosterone application\u00a0on the ovarian response to FSH in poor responders undergoing assisted reproduction technique\u2014a prospective, randomized, double-blind study","volume":"21","author":"Massin","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib63","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.fertnstert.2010.07.1077","article-title":"The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders","volume":"95","author":"Kim","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/humupd\/dmr051","article-title":"The use of androgens or androgen-modulating agents in poor responders undergoing in\u00a0vitro fertilization: A systematic review and meta-analysis","volume":"18","author":"Bosdou","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2022.03.051_bib65","first-page":"964","article-title":"Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center study","volume":"85","author":"Wang","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jc.2005-1640","article-title":"Pharmacokinetics of a testosterone gel in healthy postmenopausal women","volume":"91","author":"Singh","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2022.03.051_bib67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/den428","article-title":"Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial","volume":"24","author":"F\u00e1bregues","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib68","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/humrep\/del052","article-title":"Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH","volume":"21","author":"Balasch","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/GME.0000000000000259","article-title":"Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women","volume":"22","author":"Fooladi","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2022.03.051_bib70","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.fertnstert.2015.02.003","article-title":"Antim\u00fcllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy","volume":"103","author":"Caanen","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-010-9380-y","article-title":"Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androgens influences the steroid balance and reduces oocyte meiotic capacity","volume":"38","author":"Romero","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.ajog.2022.03.051_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.humrep.a136365","article-title":"Dynamics of follicular growth in the human: a model from preliminary results","volume":"1","author":"Gougeon","year":"1986","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: a review","volume":"39","author":"Kroboth","year":"1999","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2022.03.051_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2016.02.009","article-title":"Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF\/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial","volume":"200","author":"Kotb","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2022.03.051_bib75","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.rbmo.2014.01.019","article-title":"Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles","volume":"28","author":"Zangmo","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2022.03.051_bib76","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10815-018-1152-2","article-title":"The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency","volume":"35","author":"Wong","year":"2018","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2022.03.051_bib77","first-page":"93","article-title":"Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in\u00a0vitro fertilization: a randomized controlled trial","volume":"7","author":"Zhang","year":"2014","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2022.03.051_bib78","doi-asserted-by":"crossref","first-page":"931.e1","DOI":"10.1016\/j.fertnstert.2008.08.115","article-title":"Onset of late posttraumatic seizure after dehydroepiandrosterone treatment","volume":"91","author":"Karp","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2022.03.051_bib79","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10815-018-1383-2","article-title":"Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials","volume":"36","author":"Noventa","year":"2019","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2022.03.051_bib80","first-page":"CD009749","article-title":"Androgens ( dehydroepiandrosterone or testosterone ) for women undergoing assisted reproduction","volume":"11","author":"Nagels","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2022.03.051_bib81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/rmb2.12383","article-title":"Therapeutic effect of prolonged testosterone pretreatment in women with poor ovarian response: a randomized control trial","volume":"20","author":"Hoang","year":"2021","journal-title":"Reprod Med Biol"},{"key":"10.1016\/j.ajog.2022.03.051_bib82","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/09513590.2012.705386","article-title":"DHEA supplementation improves follicular microenviroment in poor responder patients","volume":"28","author":"Artini","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2022.03.051_bib83","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/humrep\/deq220","article-title":"Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study","volume":"25","author":"Wiser","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/GCO.0000000000000532","article-title":"Androgen supplementation in assisted reproduction: where are we in 2019?","volume":"31","author":"Montoya-Botero","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2022.03.051_bib85","first-page":"499","article-title":"Off-label use of androgens and letrozole in infertile women\u2014a multinational survey in Europe and Australia","volume":"33","author":"Andersen","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib86","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.rbmo.2021.05.021","article-title":"Testosterone does not improve ovarian response in Bologna poor responders: a randomized controlled trial (TESTOPRIM)","volume":"43","author":"Subir\u00e1","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2022.03.051_bib87","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in\u00a0vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2022.03.051_bib88","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/1933719116660849","article-title":"Testosterone for poor ovarian responders: lessons from ovarian physiology","volume":"25","author":"Polyzos","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2022.03.051_bib89","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ajog.2022.03.051_bib90","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.ajog.2022.03.051_bib91","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2022.03.051_bib92","series-title":"Cochrane handbook for systematic reviews of interventions version 6","article-title":"Chapter 14. Completing \u2019Summary of findings\u2019 tables and grading the certainty of the evidence","author":"Sch\u00fcnemann","year":"2019"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:36:39Z","timestamp":1757590599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0002937822002484"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.03.051","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}